Caisse DE Depot ET Placement DU Quebec Sells 135,328 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Caisse DE Depot ET Placement DU Quebec reduced its holdings in HCA Healthcare by 94.6%, selling 135,328 shares and holding only 7,719 shares valued at $2,667,000.
• Analysis shows HCA Healthcare's stock has seen a range of analyst ratings, with one strong buy, seven buys, and nine holds, while its average target price is $401.83.
• HCA Healthcare declared a quarterly dividend of $0.72 per share, which represents an annualized yield of 0.7% and a payout ratio of 12.11%.

Caisse DE Depot ET Placement DU Quebec lessened its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 94.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,719 shares of the company's stock after selling 135,328 shares during the quarter. Caisse DE Depot ET Placement DU Quebec's holdings in HCA Healthcare were worth $2,667,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. GAMMA Investing LLC increased its holdings in HCA Healthcare by 40,527.3% in the 1st quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock valued at $5,887,850,000 after buying an additional 1,699,713 shares during the period. Nuveen LLC bought a new stake in HCA Healthcare in the 1st quarter valued at $569,217,000. Pacer Advisors Inc. increased its holdings in HCA Healthcare by 6,237.9% in the 1st quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company's stock valued at $466,815,000 after buying an additional 1,329,618 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of HCA Healthcare by 83.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company's stock valued at $829,104,000 after purchasing an additional 1,091,416 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its stake in shares of HCA Healthcare by 49.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company's stock valued at $615,583,000 after purchasing an additional 587,036 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Down 0.8%

HCA Healthcare stock traded down $3.17 during trading hours on Monday, reaching $404.11. 996,401 shares of the company's stock traded hands, compared to its average volume of 1,110,551. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The firm has a market capitalization of $94.56 billion, a price-to-earnings ratio of 16.99, a PEG ratio of 1.27 and a beta of 1.41. The firm's 50 day moving average is $376.92 and its 200-day moving average is $357.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the prior year, the company posted $5.50 EPS. The company's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is 12.11%.

Wall Street Analysts Forecast Growth

HCA has been the topic of several recent analyst reports. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Royal Bank Of Canada reduced their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Truist Financial upped their price target on shares of HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Finally, JPMorgan Chase & Co. upped their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $401.83.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.